An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Key Takeaways Anti-amyloid drugs might be able to ward off Alzheimer’s diseaseIn a small group, such a drug cut Alzheimer’s ...

IPH4502 demonstrated preclinical anti-tumor efficacy in models of primary ... its novel and differentiated topoisomerase I inhibitor Antibody Drug Conjugate (ADC) targeting Nectin-4, has been ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327 ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...